Beneficial Effects of Resveratrol Consumption in Type 1 Diabetes patients
Phase 2
- Conditions
- type 1 diabetes.type 1 diabetesE10-E14
- Registration Number
- IRCT201710108129N11
- Lead Sponsor
- Vice chancellor for research, Bushehr University of Medical Sciences,Pardis Site, Bushehr, Iran,?
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 13
Inclusion Criteria
Inclusion Criteria: Patients with T1DM; subjects with good peripheral vein; patients on insulin treatment as long as they are on stable doses and the dosage is not changed during the course of the study.
Exclusion Criteria
Subjects on any antioxidant therapy such as vitamin supplements; having an allergy to grapes; green tea; and peanuts; patients with type 2 diabetes; pregnant women; lactating mothers; severe heart disease; hepatic disease; renal dysfunction and smoking.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c. Timepoint: Before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By Boronate Affinity Assay.;FBS. Timepoint: Before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: by enzymatic method.
- Secondary Outcome Measures
Name Time Method Glucagon. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By ELISA Method- Kits.;Frutosamin. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By ELISA Method- Kits.;Blood Urea. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By reliable Kits.;Albumin. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By reliable Kits.;Creatinine. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By reliable Kits.